Impact Factor
4.44
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.64
8,762 total citations
h5-index
87
h5 depth signal
Cited share
81.1%
1,334 of 1,645
Total citations
8,762
Citation footprint
Metric signal
5.79
External metric anchor
Self-citation
3.8%
329 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
3,114
China
962
United Kingdom
778
Italy
671
Germany
542
Citing Fields of Research
Endocrinology & Metabolism
3,428
Diabetes
2,355
Osteopathies
1,015
Adrenal Dysfunction
946
Endocrine Therapy
829
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
50,317
Articles tracked across the journal lifetime
Indexed publication set
1,645
1,334 cited publications
Last 12 months
564
47.0 publications/month
Open access share
47.7%
269 OA publications in the last year
Leading citing country
United States
3,114 citing publications
Leading citing field
Endocrinology & Metabolism
3,428 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v25n9, Sept. 1965-
v25n9, Sept. 1965-
Active Coverage
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Endocrinology & Metabolism
Diabetes
Adrenal Dysfunction
Osteopathies
Issuing & Sponsoring Bodies
Contributor
Endocrine Society
Broad Categories
Endocrinology
Metabolism
Endocrinology & Metabolism
Diabetes
Osteopathies
Adrenal Dysfunction
Endocrine Therapy
MeSH Descriptors
Endocrinology
Metabolism
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1210/clinem/dgag345
Open DOI
Impact of setmelanotide on metabolic syndrome risk in patients with proopiomelanocortin or leptin receptor deficiencies
Introduction: Patients with severe obesity due to proopiomelanocortin (POMC) or leptin receptor (LEPR) deficiencies resulting in impaired melanocortin-4 receptor (MC4R) signaling may be at risk for obesity-related comorbidities. Here, we...
02
03
DOI 10.1210/clinem/dgag413
Open DOI
Correction to: “Medical treatments for obesity: what does the future have in store?”
04
DOI 10.1210/clinem/dgag416
Open DOI
Pancreatic steatosis is not associated with impaired insulin secretion among individuals with diabetes
Aims We aimed to assess pancreatic and hepatic steatosis (PS/HS) association with residual insulin secretion and insulin resistance in individuals with diabetes. Methods Pancreatic/liver fat fractions (PFF/LFF) in magnetic resonance imag...
05
DOI 10.1210/clinem/dgag415
Open DOI
12,13-diHOME is increased during targeted temperature management and correlates with survival after cardiac arrest resuscitation
Context: Trials of targeted temperature management (TTM) after cardiac arrest (CA) have had conflicting results. Brown adipose tissue (BAT) is a thermogenic organ activated by cold temperature to regulate body temperature, systemic metab...
06
DOI 10.1210/clinem/dgag426
Open DOI
Waist circumference outperforms cardiometabolic indices for identifying hypogonadism in Klinefelter Syndrome
Context: Klinefelter syndrome (KS) is characterized by primary hypogonadism and increased cardiometabolic risk. The utility of cardiometabolic indices remains unclear. Objective: To evaluate whether anthropometric and cardiometabolic ind...
07
DOI 10.1210/clinem/dgag363
Open DOI
Genotype–phenotype correlation in partial combined 17α-hydroxylase/17,20-lyase deficiency: functional characterization of CYP17A1 variants in ten 46,XY patients
Background: Partial combined 17α-hydroxylase/17,20-lyase deficiency (PC-17OHD) is a rare 17OHD subtype with residual 17α-hydroxylase and 17,20-lyase activities. In 46,XY individuals, genital virilization is highly variable, and genotype–...
08
DOI 10.1210/clinem/dgag421
Open DOI
Iopanoic Acid in Severe Thyrotoxicosis: Rediscovering an Effective Therapy
Background: Severe thyrotoxicosis remains a high-risk endocrine emergency, particularly in thyroid storm and amiodarone-induced thyrotoxicosis (AIT), where morbidity and mortality remain substantial despite modern intensive care. Rapid r...
09
DOI 10.1210/clinem/dgag425
Open DOI
Risk-Stratified Outcomes Using the 2025 ATA Thyroglobulin Cutoff After Total Thyroidectomy in Differentiated Thyroid Cancer
Background: Differentiated thyroid cancer (DTC) is increasingly managed with total thyroidectomy (TT) without radioactive iodine (RAI). An unstimulated thyroglobulin (Tg) ≤ 0.2 ng/mL has traditionally defined remission. The 2025 American...
10
DOI 10.1210/clinem/dgag284
Open DOI
Effects of tirzepatide (GIP/GLP-1 dual receptor agonist) on cardiorenal biomarkers and functional capacity in heart failure: a systematic review and meta-analysis
Background: Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, has demonstrated clinical benefits in heart failure with preserved ejection fraction (HFpEF) and obe...
Bibliographical & Catalog Notes
Also issued online.
Official journal of the Endocrine Society.
Absorbed in part: Transactions of the American Goiter Association.
Vol. 80, no. 3 (MAR 1995)19950516 Notice published Printed on acid-free paper